CURE Pharmaceutical Holding Corp. (CURR)

OTCMKTS: CURR · Delayed Price · USD
0.310 0.000 (0.00%)
Jan 21, 2022 4:00 PM EST - Market closed
Market Cap20.17M
Revenue (ttm)4.91M
Net Income (ttm)-25.31M
Shares Out65.06M
EPS (ttm)-0.50
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume58,829
Open0.305
Previous Close0.310
Day's Range0.000 - 0.000
52-Week Range0.251 - 1.570
Beta0.80
Analystsn/a
Price Targetn/a
Earnings Daten/a

About CURR

CURE Pharmaceutical Holding Corp., together with its subsidiaries, operates as a technology focused vertically integrated drug delivery and product development company in the pharmaceutical, and health and wellness markets. It focuses on the development and manufacturing of drug formulation and drug delivery technologies in novel dosage forms to enhance drug safety, efficacy, and patient adherence. The company operates through two business segments: Cure and Sera Labs. Its pharmaceutical drug programs include CUREfilm Blue, a sildenafil oral th...

IndustryDrug Manufacturers-Specialty & Generic
Founded2011
Employees39
Stock ExchangeOTCMKTS
Ticker SymbolCURR
Full Company Profile

News

Sera Labs, a Subsidiary of CURE Pharmaceutical, Consummates Exclusive International Distribution Agreement With Leadi...

Northern Response International To Distribute Seratopical Revolution® Masstige Line Northern Response International To Distribute Seratopical Revolution® Masstige Line

1 month ago - GlobeNewsWire

CURE Pharmaceutical Receives Patent Approval for Its CUREfilm Blue™ Technology

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company focused on pharmaceutical and he...

2 months ago - Business Wire

CURE Pharmaceutical Q2 2021 Revenue Spikes 700% After Increased Sales From Seba Labs Products Including A CVS Deal

Pharmaceutical company CURE Pharmaceutical Holding Corp. (OTC:CURR) announced earnings results on Tuesday for the quarter ended June 30, revealing revenue of $2.1 million. That's a year-over-year increa...

5 months ago - Benzinga

CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), today announced results for the quarter ended June 30, 2021, including the following highlights: Revenue of $2.1 million r...

5 months ago - Business Wire

Seratopical Revolution Skincare Line by The Sera Labs Inc., a CURE Pharmaceutical Company, will be Available for Purc...

LOS ANGELES--(BUSINESS WIRE)--Sera Labs, a subsidiary of CURE Pharmaceutical Holding Corp. (OTC: CURR), today announced that all six facial products of the Seratopical Revolution skincare line will be a...

5 months ago - Business Wire

CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health...

7 months ago - Business Wire

Federally Compliant Medical Cannabis In The US? One Company Is Doing It

CURE Pharmaceutical (OTC:CURR) has signed an agreement with Biopharmaceutical Research Company (BRC) to produce federally compliant medical cannabis, CBD and THC products. BRC will provide the cannabino...

7 months ago - Benzinga

CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Vet...

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership ag...

7 months ago - Business Wire

CURE Pharmaceutical Schedules Investor Webcast for Thursday, May 27, 2021

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, today announced that it will hold a webcast with th...

8 months ago - Business Wire

CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Ps...

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, reported its financial results and provided an oper...

8 months ago - Business Wire

CURE Pharmaceutical Receives ISO Certification for Laboratory and Manufacturing Facility

LOS ANGELES--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has ...

8 months ago - Business Wire

CURE Pharmaceutical to Present at the 2021 Sequire Cannabis Conference on Tuesday, April 20, at 2 p.m. EDT/11 a.m.

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that Rob Davidson, CURE's Chief Exe...

9 months ago - Business Wire

CURE Pharmaceutical Reports Increase in Revenue to $7.7 Million on a Pro Forma Basis in 2020

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, reported its financial and operating results for th...

9 months ago - Business Wire

CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based...

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it h...

10 months ago - Business Wire

CURE Pharmaceutical Launches Psychedelic Oral Film Program Targeting the Treatment of Mental Health Disorders

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it h...

10 months ago - Business Wire

CURE Pharmaceutical Announces Addition of Two New Clinical Development Programs Targeting Anti-Seizure and Antiviral ...

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it h...

10 months ago - Business Wire

CURE Pharmaceutical's Subsidiary Sera Labs Launches National Television, Radio & Digital Advertising Campaign for Nut...

LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product development ...

10 months ago - Business Wire

CURE Pharmaceutical Announces Promotions and Additions to Board of Directors

OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness pro...

11 months ago - Business Wire

Sera Labs Unveils ImmunD₃™ an Important New Offering to the Nutri-Strips™ Product Line; Launches New Digital E-commer...

LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--According to the National Institute of Health (NIH) more than 50 percent of people worldwide have Vitamin D insufficiency. In response, Sera...

11 months ago - Business Wire

Sera Labs, Inc. Wins Prestigious Retail Excellence Award

LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--The retailers have spoken! Sera Labs, Inc., the wholly owned subsidiary of CURE Pharmaceutical Holdings (OTCQB: CURR), announced today they ...

11 months ago - Business Wire

CURE Pharmaceutical to Present at 2021 NobleCon17 on Tuesday, January 19 at 3pm EST/12pm PST

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health...

1 year ago - Business Wire

CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp (“CURE” or the “Company”) (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the ...

1 year ago - Business Wire

CURE Pharmaceutical to Present at LD Micro on December 15, Schedules Investor Video Webcast for December 17

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTCQB: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and dru...

1 year ago - Business Wire

CURE Pharmaceutical Issues Letter to Shareholders

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug ...

1 year ago - Business Wire

CURE Pharmaceutical Closes $10 Million Financing

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Closes $10 Million Financing

1 year ago - Business Wire